Code Details & Principles for M2981
Code details & principles for
M2981
- Chapter 12 / Bladder
| Code | Description | Chapter/Sub-Chapter | Code Specific Guidance |
|---|---|---|---|
| M2981 | Endoscopic vesico-ureteric anti-reflux procedure (and bilateral) (including cystoscopy) | 12.3.0 Bladder |
Unacceptable Combinations for M2981
| CCSD Code (unacceptable combination) | Narrative (unacceptable combination) | Date Added |
|---|---|---|
| G4530 | Catheterless oesophageal pH monitoring (e.g. Bravo) | 2010-01-20 |
| M3000 | Endoscopic examination of ureter (+/- cystoscopy and insertion/removal of stent) +/- retrograde pyelography | 2011-10-25 |
| M4510 | Diagnostic endoscopic examination of bladder (flexible cystoscopy) including any biopsy | 2014-06-17 |
| M4514 | Endoscopic examination of bladder (rigid cystoscopy) including any biopsy | 2015-03-05 |
| M7920 | Dilatation of urethra (including cystoscopy) | 2010-01-20 |
Coding Principles
These coding principles set out how the authors intend that the codes and narratives within the CCSD Schedule are interpreted and used. The outputs are available to be used by all individual insurers and providers including CCSD and non-CCSD members. Please note that:
- The CCSD Group does not discuss nor determine classifcations, reimbursement or fees - all insurers will have their own view on these matters
- The inclusion of a procedure code and/or its associated coding principles in the CCSD Schedule does not necessarily mean that it is endorsed by all members of the CCSD Group and codes may or may not be included in individual insurers' own Schedules or covered
- The coding principles are non-exhaustive guidelines only - each individual insurer may choose whether or not to adopt an individual combination of codes in practice and you will need to contact the insurer for further information